BOSTON--(BUSINESS WIRE)--Feb. 7, 2005--Boston Life Sciences, Inc. (NASDAQ: BLSI), a biotechnology company focused in the diagnosis and treatment of central nervous system diseases, has announced that Peter Savas, the Company’s Chairman and Chief Executive Officer, and Mark Pykett, President and Chief Operating Officer, will give an investor presentation and an overview of the Company at a luncheon in New York City on Tuesday, February 8, 2005, at 12:00PM EST.
